Strategic Alliance Between Brexogen and BMI Korea Advances Exosome Therapeutics Development Brexogen and BMI Korea form a pivotal technology transfer agreement to enhance exosome-based therapeutics, marking a significant milestone in regenerative medicine.

Strategic Alliance Between Brexogen and BMI Korea Advances Exosome Therapeutics Development #South_Korea #Seoul #Brexogen #BMI_Korea #exosome_therapy